Research and Development
Wickham Laboratories Announces New In Vitro Pyrogenicity Testing Method
July 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
AstraZeneca trigger $10 million milestone payment for Heptares in immuno-oncology candidate
July 6, 2016 Research and Development, Sales and Marketing AstraZeneca, Heptares
Sanofi says to co-develop Zika vaccine with US government
July 6, 2016 Research and Development, Sales and Marketing Sanofi, US government, Vaccine, Zika virus, drug development, research
Bristol-Myers Squibb acquires Cormorant Pharmaceuticals in deal worth up to $425 million
July 6, 2016 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, cormorant
Sanofi signs confidentiality agreement with Medivation for due diligence access for potential deal
July 6, 2016 Research and Development, Sales and Marketing Financial, M&A, MA, Medivation, Sanofi, deal, offer
Nice rejects BMS’ immunotherapy Opdivo for previously treated kidney cancer on pricing
July 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Bristol-Myers Squibb, NICE, QALY, immunotherapy, opdivo, regulation
UCB scores Japanese approval for seizure therapy, Vimpat
July 5, 2016 Manufacturing and Production, Research and Development Daiichi Sankyo, Japan, UCB, japanese
Sanofi, Regeneron say cholesterol drug Praluent approved in Japan
July 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Japan, Regeneron, Sanofi, cardiovascular, cholestrol, praleunt
Eisai launches cancer drug Lenvatinib in Mexico
July 4, 2016 Research and Development, Sales and Marketing Cancer, Eisai, Mexico, lenvatinib, product launch
Allergan says its double chin correction therapy Belkyra gets positive opinion from Swedish regulators
July 4, 2016 Research and Development, Sales and Marketing Allergan, Belkyra, Botox, EU, Sweden, double chin, drug trial
Amgen says its blood cancer drug gets European backing for extended indication
July 4, 2016 Research and Development, Sales and Marketing Amgen, European Commission, Kyprolis, blood cancer, drug trial
Merck says its Erbitux in combination with Folfox improves outcomes in colorectal cancer
July 4, 2016 Research and Development, Sales and Marketing Cancer, China, ESMO, Merck, colorectal cancer, drug trial, research, study
Weekly Movers: Regulus, Nymox, Akers…
July 4, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shares, drug trial, markets, stocks
AstraZeneca licenses skin-condition drug to Leo Pharma for $115 million upfront
July 1, 2016 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Deals, Licencing, Loe Pharna, Valeant, drug development
US doctors received $6.5 billion from drug, device firms in 2015
July 1, 2016 Medical Communications, Research and Development, Sales and Marketing US, affordable care act, pharma, regulation
